Oramed Pharmaceuticals (ORMP) Asset Utilization Ratio (2016 - 2025)

Oramed Pharmaceuticals' (ORMP) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2025, down 15.33% on a QoQ basis from 0.01 in Q3 2025.

Oramed Pharmaceuticals (ORMP) Asset Utilization Ratio (2016 - 2025) Analysis & Trends

Oramed Pharmaceuticals (ORMP) has 8 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2025.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.01 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01 (changed N/A YoY) and the FY2025 annual result came in at 0.01, changed N/A from the prior year.
Asset Utilization Ratio fell to 0.01 in Q4 2025, from 0.01 in the prior quarter.
In the past five years, Asset Utilization Ratio ranged from a high of 0.05 in Q3 2021 to a low of 0.01 in Q4 2023.
A 4-year average of 0.02 and a median of 0.02 in 2022 frame the typical range for Asset Utilization Ratio.
The widest YoY moves for Asset Utilization Ratio: up 31.65% in 2023, down 66.92% in 2023.
Tracing ORMP's Asset Utilization Ratio over 4 years: stood at 0.05 in 2021, then sank by 60.53% to 0.02 in 2022, then slumped by 66.92% to 0.01 in 2023, then surged by 49.28% to 0.01 in 2025.
The last three Asset Utilization Ratio figures came in at 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.38
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	0.90
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.13
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.13
10	Oramed Pharmaceuticals	197.61 Mn	197.61 Mn	-	-

Download Data